These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of regadenoson for measurement of fractional flow reserve. Prasad A; Zareh M; Doherty R; Gopal A; Vora H; Somma K; Mehra A; Clavijo LC; Matthews RV; Shavelle DM Catheter Cardiovasc Interv; 2014 Feb; 83(3):369-74. PubMed ID: 23765847 [TBL] [Abstract][Full Text] [Related]
3. Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory. Stolker JM; Lim MJ; Shavelle DM; Morris DL; Angiolillo DJ; Guzman LA; Kennedy KF; Weber E; Zareh M; Neumayr RH; Zenni MM Cardiovasc Revasc Med; 2015; 16(5):266-71. PubMed ID: 26242981 [TBL] [Abstract][Full Text] [Related]
4. Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve. Arumugham P; Figueredo VM; Patel PB; Morris DL EuroIntervention; 2013 Feb; 8(10):1166-71. PubMed ID: 23164748 [TBL] [Abstract][Full Text] [Related]
5. Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement. van Nunen LX; Lenders GD; Schampaert S; van 't Veer M; Wijnbergen I; Brueren GR; Tonino PA; Pijls NH EuroIntervention; 2015 Dec; 11(8):905-13. PubMed ID: 25136887 [TBL] [Abstract][Full Text] [Related]
6. Intravenous regadenoson with aminophylline reversal is safe and equivalent to intravenous adenosine infusion for fractional flow reserve measurements. Edward JA; Lee JH; White CJ; Morin DP; Bober R Clin Cardiol; 2018 Oct; 41(10):1348-1352. PubMed ID: 30125368 [TBL] [Abstract][Full Text] [Related]
7. Comparison of regadenoson and nitroprusside to adenosine for measurement of fractional flow reserve: A systematic review and meta-analysis. Lee JZ; Singh N; Nyotowidjojo I; Howe C; Low SW; Nguyen T; Pinto D; Kumar G; Lee KS Cardiovasc Revasc Med; 2018 Mar; 19(2):168-174. PubMed ID: 28888873 [TBL] [Abstract][Full Text] [Related]
8. Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. De Luca G; Venegoni L; Iorio S; Giuliani L; Marino P JACC Cardiovasc Interv; 2011 Oct; 4(10):1079-84. PubMed ID: 22017932 [TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve. Rudzinski W; Waller AH; Rusovici A; Dehnee A; Nasur A; Benz M; Sanchez S; Klapholz M; Kaluski E Catheter Cardiovasc Interv; 2013 Feb; 81(3):540-4. PubMed ID: 22961876 [TBL] [Abstract][Full Text] [Related]
10. Comparison of intracoronary versus intravenous administration of adenosine for measurement of coronary fractional flow reserve. Schlundt C; Bietau C; Klinghammer L; Wiedemann R; Rittger H; Ludwig J; Achenbach S Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25908694 [TBL] [Abstract][Full Text] [Related]
11. Comparison of hyperemic efficacy between central and peripheral venous adenosine infusion for fractional flow reserve measurement. Seo MK; Koo BK; Kim JH; Shin DH; Yang HM; Park KW; Lee HY; Kang HJ; Kim HS; Oh BH; Park YB Circ Cardiovasc Interv; 2012 Jun; 5(3):401-5. PubMed ID: 22647519 [TBL] [Abstract][Full Text] [Related]
12. Detection of coronary stenosis with myocardial contrast echocardiography using regadenoson, a selective adenosine A2A receptor agonist. Le DE; Bragadeesh T; Zhao Y; Wang YG; Zha D; Kaul S Eur Heart J Cardiovasc Imaging; 2012 Apr; 13(4):298-308. PubMed ID: 22067143 [TBL] [Abstract][Full Text] [Related]
13. Variability of fractional flow reserve according to the methods of hyperemia induction. Lim WH; Koo BK; Nam CW; Doh JH; Park JJ; Yang HM; Park KW; Kim HS; Takashima H; Waseda K; Amano T; Kato D; Kurita A; Oi M; Toyofuku M; van Nunen L; Pijls NH Catheter Cardiovasc Interv; 2015 May; 85(6):970-6. PubMed ID: 25413590 [TBL] [Abstract][Full Text] [Related]
14. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Palani G; Ananthasubramaniam K Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345 [TBL] [Abstract][Full Text] [Related]
15. Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. Leone AM; Porto I; De Caterina AR; Basile E; Aurelio A; Gardi A; Russo D; Laezza D; Niccoli G; Burzotta F; Trani C; Mazzari MA; Mongiardo R; Rebuzzi AG; Crea F JACC Cardiovasc Interv; 2012 Apr; 5(4):402-8. PubMed ID: 22516396 [TBL] [Abstract][Full Text] [Related]
17. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. Ntalianis A; Sels JW; Davidavicius G; Tanaka N; Muller O; Trana C; Barbato E; Hamilos M; Mangiacapra F; Heyndrickx GR; Wijns W; Pijls NH; De Bruyne B JACC Cardiovasc Interv; 2010 Dec; 3(12):1274-81. PubMed ID: 21232721 [TBL] [Abstract][Full Text] [Related]
18. Rapid detection of coronary artery stenoses with real-time perfusion echocardiography during regadenoson stress. Porter TR; Adolphson M; High RR; Smith LM; Olson J; Erdkamp M; Xie F; O'Leary E; Wong BF; Eifert-Rain S; Hagen ME; Abdelmoneim SS; Mulvagh SL Circ Cardiovasc Imaging; 2011 Nov; 4(6):628-35. PubMed ID: 21946702 [TBL] [Abstract][Full Text] [Related]
19. Intravenous nicorandil versus adenosine for fractional flow reserve measurement: a crossover, randomized study. Nishi T; Kitahara H; Fujimoto Y; Nakayama T; Nagashima K; Hanaoka H; Kobayashi Y Heart Vessels; 2018 Dec; 33(12):1570-1575. PubMed ID: 29858919 [TBL] [Abstract][Full Text] [Related]
20. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Casella G; Leibig M; Schiele TM; Schrepf R; Seelig V; Stempfle HU; Erdin P; Rieber J; König A; Siebert U; Klauss V Am Heart J; 2004 Oct; 148(4):590-5. PubMed ID: 15459587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]